Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).
Besse
T
T
Department of Renal and Pancreatic Transplantation, University of Louvain Medical School, Brussels, Belgium.
Malaise
J
J
Mourad
M
M
Pirson
Y
Y
Hope
J
J
Awwad
M
M
White-Scharf
M
M
Squifflet
J P
JP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018801:CD2 Antigens / Q000276:immunology; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; C105249:LO-CD2a